Arturo Casadevall
@ACasadevall1
Followers
10K
Following
6K
Media
385
Statuses
4K
Professor and Chair, Department of Molecular Microbiology and Immunology, Johns Hopkins School of Public Health
Joined December 2014
RT @GeneticsGSA: 📢 NEW GENOME ALERT in #G3journal. @ACasadevall1 and team published several chromosome-level genome assemblies and annotati….
0
4
0
RT @JohnsHopkinsMMI: Here's an example of a Wavelengths book written in an accessible way -- 'WHAT IF FUNGI WIN' by @JHU_BDPs @JohnsHopkins….
0
2
0
RT @mtmdphd: Prepare now to use convalescent plasma for the next pandemic. Whether it’s H5N1 avian flu or something else, convalescent plas….
statnews.com
Whether the next pandemic is caused by H5N1 bird flu or something else, we must prepare now to use convalescent plasma to treat patients.
0
3
0
RT @JohnsHopkinsMMI: CAN WE STOP KILLER FUNGI? . Fungal diseases are more common, more dangerous & more difficult to treat. This fascinatin….
0
4
0
RT @DrMJoyner: More evidence the “VaxPlasma” form of Convalescent Plasma is ++ in BCell depleted patents with COVID @jwsenefeld @ScottWr….
medrxiv.org
Background COVID-19 convalescent plasma (CCP) is obtained from people recently recovered from COVID-19 and contains viral-neutralizing antibodies. Because such treatment is safe and effective against...
0
4
0
RT @Danfqsmith: Fun project that started with looking at whether or not there is chaos during Galleria infections, and wound up also findin….
0
2
0
That is a great topic and title. What if fungi win? is also the title of my book with @stephaniedesmon on the wonders and threats in the fungal world.
Mat Fischer @fisher_mat . kicks off #mycology2025 @FungalUpdate with the question “What if Fungi win?” - and the sobering conclusion that they are too good at drug resistance to lose! Big need for surveillance and stewardship. @eurconfmedmycol
0
14
28
I don't understand why articles like this one never mention that we have an option for preventing disease: measles gamma globulin has a 100% efficacy in preventing disease in exposed vulnerable children. @nytimes See reference:.
nytimes.com
Infants are at higher risk of complications from the measles but can’t be vaccinated right away.
0
1
2
RT @RadioHealthJrnl: @ACasadevall1 says major catastrophes in earth’s history, like mass extinctions of plants and animals, have been immed….
0
2
0
RT @PeterHotez: @DrMJoyner @ACasadevall1 @ShohamTxID @DrJPHenderson There’s a well established post exposure prophylaxis measles immune glo….
0
1
0
The pandemic crisis may be over, but SARS-CoV-2 remains a major problem for the immunocompromised who do not make good antibody responses. European RCT confirms efficacy of COVID-19 convalescent plasma (CCP) in this population. CCP is FDA licensed in US @DrMJoyner
2
7
23
RT @JHUPress: Tuesday, 3/4! Dr. Arturo Casadevall (@ACasadevall1) and NPR's Emily Kwong (@emilykwong1234) talk all things fungi at the John….
eventbrite.com
Could fungal pathogens outsmart us before we find ways to combat them? Learn how scientists are trying to build a fungal-resistant future
0
3
0
As physicians confront the widening measles outbreak it is important to keep in mind that we have a highly effective means of protecting those exposed - hyperimmune IgG. It showed 100% efficacy in the 2013 NYC outbreak. @DrMJoyner @DrNeilStone @EricTopol
0
15
33
RT @LabWaggoner: A call for the United States to continue investing in science.@JVirology @ACasadevall1 @BladerLab….
0
4
0
RT @nyehya: @jisvagoimperial @ACasadevall1 Este es el índice mi admirado y estimado Jis. Comencé a leerlo hoy.
0
1
0
RT @DrMJoyner: @ACasadevall1 5 yrs ago - CP made & continues to make a real difference @ShohamTxID @jhDavidSullivan @ScottWrightMD ….
wsj.com
A school physician’s approach to measles in 1934 has lessons for the coronavirus.
0
4
0
RT @DrMJoyner: Was great to visit @LebovitsM and his family plus community on their home turf yesterday @ScottWrightMD @ACasadevall1….
0
1
0
RT @dfocosi: In this editorial in @TheLancetInfDis with @ACasadevall1 , we show how SARS-CoV-2 evolution once again defeated an anti-Spike….
thelancet.com
In The Lancet Infectious Diseases, Ghady Haidar and colleagues1 report the outcomes of the AstraZeneca-sponsored SUPERNOVA randomised controlled trial, which tested the efficacy of the anti-spike...
0
7
0
RT @mbiojournal: Would global warming bring an increase of invertebrate-associated cutaneous invasive fungal infections? @ACasadevall1 #mBi….
0
8
0